227 related articles for article (PubMed ID: 23317937)
1. Risperidone, a risk factor for valproate-induced encephalopathy?
Rodrigues-Silva N; Venâncio Â; Bouça J
Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
[TBL] [Abstract][Full Text] [Related]
2. Valproate-related hyperammonemic encephalopathy: report of 1 case.
Selvi Y; Annagur BB; Sayin AA; Akbaba N
J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
[No Abstract] [Full Text] [Related]
3. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
4. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
5. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
Elgudin L; Hall Y; Schubert D
Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
[TBL] [Abstract][Full Text] [Related]
6. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
Stewart JT
J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
[No Abstract] [Full Text] [Related]
7. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
8. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
Abreu LN; Issler C; Lafer B
Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
[No Abstract] [Full Text] [Related]
9. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
Dealberto MJ
Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
[TBL] [Abstract][Full Text] [Related]
10. [Valproate-induced hyperammonemic encephalopathy].
Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
[TBL] [Abstract][Full Text] [Related]
11. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
Panda S; Radhakrishnan K
J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia induced by interaction of valproate and quetiapine.
Halaby A; Haddad R; Naja WJ
Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
[TBL] [Abstract][Full Text] [Related]
13. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
Cheng M; Tang X; Wen S; Yue J; Wang H
Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
[TBL] [Abstract][Full Text] [Related]
14. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
Bocchetta A; Siddu A; Sardu C; Sarnicola A; Martinelli V
J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
[No Abstract] [Full Text] [Related]
15. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS
Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
[No Abstract] [Full Text] [Related]
16. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
Dawson LP; Lee SJ; Hollander YS
Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
[No Abstract] [Full Text] [Related]
17. Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.
Carlson T; Reynolds CA; Caplan R
J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):356-361. PubMed ID: 17314721
[TBL] [Abstract][Full Text] [Related]
18. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
Patel N; Landry KB; Fargason RE; Birur B
Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
[TBL] [Abstract][Full Text] [Related]
19. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
[TBL] [Abstract][Full Text] [Related]
20. Encephalopathy with combined lithium-risperidone administration.
Boora K; Xu J; Hyatt J
Acta Psychiatr Scand; 2008 May; 117(5):394-5; discussion 396. PubMed ID: 18331580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
